Association between Telomere Length and Geriatric Status in Centenarians
https://doi.org/10.37586/2949-4745-2-2023-102-107
Abstract
Aim. To evaluate the association between telomere length and frailty and individual geriatric syndromes in older adults.
Materials and methods. The database of a hundred-year-old citizen of the city of Moscow was analyzed. The analysis was carried out using the data driven from the Comprehensive Geriatric Assessment (CGA), in particular, Age is not a Hindrance Scale, the Barthel index, Instrumental Activities of Daily Living (IADL), Mini Nutritional Assessment (MNA), Mini-Mental State Examination (MMSE), and Geriatric Depression Scale (GDS-15). DNA was isolated from frozen blood and a study of telomere length was performed. The comparison of telomere length in groups of patients with frailty and individual geriatric syndromes was carried out.
Results. The study involved 60 people (98±1.8 years, 86.7% women). The analysis found no differences in telomere length in study participants with and without frailty, as well as in the analysis of individual geriatric syndromes. No correlation was found between telomere length and the results of comprehensive geriatric assessment scales. There was no difference in telomere length in patients who died within 3 years of follow-up and no.
Conclusion. No relationship was found between telomere length and frailty. Thus, telomere length cannot be considered as a reliable biomarker of functional aging.
About the Authors
K. A. EruslanovaRussian Federation
Ksenia A. Eruslanova, MD, PhD, Head of Laboratory
Laboratory of Cardiovascular Aging
Moscow
Phone: +7(499)1877809
S. O. Zhikrivetskaya
Russian Federation
Svetlana Olegovna Zhikrivetskaya, PhD in Biology, Researcher
Moscow
Yu. V. Kotovskaya
Russian Federation
Yulia V. Kotovskaya, MD, PhD, professor, Deputy Director
Moscow
Phone: +7(499)1877809
O. N. Tkacheva
Russian Federation
Olga N. Tkacheva, MD, PhD, professor, corresponding member of the Russian Academy of Sciences, Director
Moscow
Phone: +7(499)1876467
References
1. United Nations. World population ageing (2019). https://www.un.org/en/development/desa/population/publications/pdf/ageing/WorldPopulationAgeing2019-Highlights.pdf.
2. Dzau VJ, Inouye SK, Rowe JW, Finkelman E, Yamada T. Enabling healthful aging for all — the National Academy of Medicine Grand Challenge in Healthy Longevity. N Engl J Med. 2019;381:1699–1701. — DOI: 10.1056/NEJMp1912298
3. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М., Остапенко В.С., Мхитарян Э.А., Шарашкина Н.В., Тюхменев Е.А., Переверзев А.П., Дудинская Е.Н. Клинические рекомендации «Старческая астения». Российский журнал гериатрической медицины. 2020;(1):11–46
4. Ткачева О.Н., Котовская Ю.В., Рунихина Н.К., Фролова Е.В., Наумов А.В., Воробьева Н.М., Остапенко В.С., Мхитарян Э.А., Шарашкина Н.В., Тюхменев Е.А., Переверзев А.П., Дудинская Е.Н. Клинические рекомендации «Старческая астения». Часть 2. Российский журнал гериатрической медицины. 2020;(2):115–130. — DOI: 10.37586/2686-8636-2-2020-115-130
5. Lorenzi M, Bonassi S, Lorenzi T, Giovannini S, Bernabei R, Onder G. A review of telomere length in sarcopenia and frailty. Biogerontology. 2018;19:209–221. — DOI: 10.1007/s10522-018-9749-5
6. Fasching CL. Telomere length measurement as a clinical biomarker of aging and disease. Crit Rev Clin Lab Sci. 2018;55:443–465. — DOI: 10.1080/10408363.2018.1504274
7. Rossiello F., Jurk D., Passos J.F., et al. Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol 24, 135–147 (2022). — DOI: 10.1038/s41556-022-00842-x
8. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. — DOI: 10.1016/S0140-6736(03)12384-7
9. El Assar M, Angulo J, Rodríguez-Mañas L. Frailty as a phenotypic manifestation of underlying oxidative stress. Free Radic Biol Med. 2020;149:72–77. — DOI: 10.1016/j.freeradbiomed.2019.08.011
10. Araújo Carvalho AC, Tavares Mendes ML, da Silva Reis MC, Santos VS, Tanajura DM, Martins-Filho PRS. Telomere length and frailty in older adults-A systematic review and meta-analysis. Ageing Res Rev. 2019;54:100914. — DOI: 10.1016/j.arr.2019.100914
11. Шарашкина Н.В., Ткачева О.Н., Рунихина Н.К., Арефьева М.С., Ерусланова К.А., Остапенко В.С., Котовская Ю.В. Комплексная гериатрическая оценка — основной инструмент работы врача-гериатра. Российский журнал гериатрической медицины. 2022;(4):210–227. — DOI: 10.37586/2686-8636-4-2022-210-227
12. Muezzinler A, Zaineddin AK, Brenner H.A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev. 2013;12:509–519. — DOI: 10.1016/j.arr.2013.01.003
13. Blackburn EH, Epel ES, Lin J. Human telomere biology: a contributory and interactive factor in aging, disease risk, and protection. Science. 2015;350:1193–1198. — DOI: 10.1126/science.aab3389
14. Cawthon RM, Smith KR, O'Brien E, Sivatchenko A, Kerber RA. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet. 2003;361:393–395. — DOI: 10.1016/S0140-6736(03)12384-7
15. Svensson J, Karlsson MK, Ljunggren O, Tivesten A, Mellstrom D, Moverare-Skrtic S. Leukocyte telomere length is not associated with mortality in older men. Exp Gerontol. 2014;57:6–12. — DOI: 10.1016/j.exger.2014.04.013
16. Needham BL, Rehkopf D, Adler N, Gregorich S, Lin J, Blackburn EH, Epel ES. Leukocyte telomere length and mortality in the National Health and Nutrition Examination Survey, 1999–2002. Epidemiology. 2015;26:528–535. — DOI: 10.1097/EDE.0000000000000299
17. Woo J, Yu R, Tang N, Leung J. Telomere length is associated with decline in grip strength in older persons aged 65 years and over. Age (Dordr) 2014;36:9711. — DOI: 10.1007/s11357-014-9711-7
18. El Assar M, Angulo J, Carnicero JA, et al. Association between telomere length, frailty and death in older adults. Geroscience. 2021;43(2):1015–1027. — DOI:10.1007/s11357-020-00291-0
19. Wang Q, Zhan Y, Pedersen NL, Fang F, Hagg S. Telomere length and all-cause mortality: a meta-analysis. Ageing Res Rev. 2018;48:11–20. — DOI: 10.1016/j.arr.2018.09.002
20. Zhan Y, Liu XR, Reynolds CA, Pedersen NL, Hagg S, Clements MS. Leukocyte telomere length and all-cause mortality: a between-within twin study with time-dependent effects using generalized survival models. Am J Epidemiol. 2018;187:2186–2191. — DOI: 10.1093/aje/kwy128
21. Martin-Ruiz CM, Gussekloo J, van Heemst D, von Zglinicki T, Westendorp RG. Telomere length in white blood cells is not associated with morbidity or mortality in the oldest old: a population-based study. Aging Cell. 2005;4:287–290. — DOI: 10.1111/j.1474–9726.2005.00171.x
22. Rodríguez-Mañas L, Féart C, Mann G, Viña J, Chatterji S, Chodzko-Zajko W, Gonzalez-Colaço Harmand M, Bergman H, Carcaillon L, Nicholson C, Scuteri A, Sinclair A, Pelaez M, van der Cammen T, Beland F, Bickenbach J, Delamarche P, Ferrucci L, Fried LP, Gutiérrez-Robledo LM, Rockwood K, Rodríguez Artalejo F, Serviddio G, Vega E, FOD-CC group (Appendix 1) Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. J Gerontol A Biol Sci Med Sci. 2013;68:62–67. — DOI: 10.1093/gerona/gls119
23. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002 May 15;30(10):e47.
24. Strazhesko I, Tkacheva O, Boytsov S, et al. Association of Insulin Resistance, Arterial Stiffness and Telomere Length in Adults Free of Cardiovascular Diseases. PLoS One. 2015;10(8):e0136676.
25. Dagnall CL, Hicks B, Teshome K, Hutchinson AA, Gadalla SM, Khincha PP, Yeager M, Savage SA. Effect of pre-analytic variables on the reproducibility of qPCR relative telomere length measurement. PLoS One. 2017 Sep 8;12(9):e0184098.
Review
For citations:
Eruslanova K.A., Zhikrivetskaya S.O., Kotovskaya Yu.V., Tkacheva O.N. Association between Telomere Length and Geriatric Status in Centenarians. Problems of Geroscience. 2023;(2):102-107. (In Russ.) https://doi.org/10.37586/2949-4745-2-2023-102-107